Intraarterial chemoembolisation with lipiodol and epirubicin in hepatocellular cancer - Improved survival in some patients?

Annales Chirurgiae et Gynaecologiae

Volumn 88, Issue 4, 1999, Pages 264-268

  Karlson, B M ^a   Lofberg A M ^a   Lorelius L E ^a   Jacobson, G ^a   Haglund, U ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemoembolisation; Hepatocellular cancer; Survival

Indexed keywords

DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PORTAL VEIN OBSTRUCTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; EPIRUBICIN; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0033398434     PISSN: 03559521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cancer Incidence in Sweden 1992. Centre of Epidemiology. The National Board of Health and Welfare.
2. Simonetti RG, Liberati A, Angiolini C, Pagliaro L: Treatment of hepatocellular: carcinoma: A systematic review of randomized controlled trials. Ann Oncol 8: 117-136, 1997
3. Ebara M, Ohto M, Sugiura N, Kita K, Yoshikawa M, Okuda K, Kondo F, Kondo Y: Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. J Gastroenterology Hepatol 5(6): 616-626, 1990
4. Livraghi T, Salmi A, Bolondi L, Marin G, Arienti V, Montin F, Vettori C: Small hepetocellular carcinoma: Percutaneous alcohol injection - results in 23 patients. Radiology 168. 313-317, 1988
5. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, Torzilli G: No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian co-operative study group. J Hepatol 22: 522-526, 1995
6. Vennook AP. Treatment of hepatocellular carcinoma: Too many options? J Clin Onc 12(6):1323-1334, 1994
7. Bhattacharya S, Dhillon AP, Winslet MC, Davidsson BR, Shukla N, Datta Gupta S, Al-Mufti K, Hobbs KEF: Human liver cancer cells and endothelial cells incorporate iodized oil. Br J Cancer 73. 877-881, 1996
8. Groupe d'etude et de traitment du carcinome hépatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332: 1256-1261, 1995
9. Hafstrom LO, Naredi P, Lindnér P, Scherztén T: Treatment of primary liver cancer. Eur J Surg 164: 569-574, 1998
10. Madden MV, Krige JEJ, Bailey S, Beningfield SJ, Geddes C, Werner JD, Terblanche J: Randomised trail of targeted chemotherapy with lipiodol and 5-epiepirubicin compared with symtomatic treatment for hepatoma. Gut 34: 1598-1600, 1993
11. Yoshikawa M, Hiromitsu S, Ebara M, Iijima T, Iwama S, Endo F, Kimura M, Shimamura Y, Suzuki Y, Nakano T, Fukuyama Y, Fujise K, Nambu M, Othon M: A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 33 (Suppl): S149-152, 1994
12. Nakamura H, Mitani T, Murakami T, Hashimota T, Tsuda K, Nakanishi K, Ishida T, Momoda K, Hori S, Kazuka T, Monden M, Kuroda C: Five-year survival after transcatheter chemoembolization for hepoatocellular carcinoma. Cancer Chemother Pharmacol 33 (Suppl): S89-92, 1994
13. Kawai S, Okamura J, Ogawa M, Ohashi Y, Tani M, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shtmamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Mikuriya S, Monden M, Yumoto Y, Mori T, Oda T, and The cooperative study groupe for liver treatment of Japan: Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). Cancer Chemother Pharmacol 31 (Suppl 1): S1-S6, 1992
14. Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, Hayashi S, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y. Jinno K, -Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y,Makino M, Masuzawa M, Yumota Y, Mori T, Oda T, The cooperative study group for liver cancer treatment of Japan: Prospective and randomised clinical trial for the treatment of hepatocellular carcinoma - a comparison between L-TAE with Adnamycin: preliminary results (second cooperative study) Cancer Chemother Pharmacol 33 (Suppl): S 97-102, 1994
15. Watanabe S, Nishioka M, Ohta Y, Ogawa N, Ito S, Yamamoto Y, Cooperative study group for liver canter treatment in Shikiku area: Prospective and randomized trail of hemoembolization therapy in patients with advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 33 (Suppl): S93-96, 1994
16. Yamashita Y, Takahashi M, Shinzato J, Bussaka H, Baba Y, Oguni T: Evaluation of oil-soluble FUdR ester for transcatherter arterial treatment of hepatomas. Ann Oncol 3: 367-370, 1992
17. Horiguchi Y, Sekoguchi B, Imai H, Suszuki T, Kubo H, Itoh H, Itoh M: Treatment of choise for unresectable small liver cancer: Percutaneous ethanol injectio therapy or transarterial chemoembolization therapy Cancer Chemother Pharmacol 33 (Suppl): S111-114, 1994
18. 131Iodine-lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma. Cancer 76: 2202-2210, 1995
19. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163: 387-394, 1992
20. Horiguchi Y, Itoh M, Takagawa H, Imai H, Kamei A, Sekoguchi B, Nagamura Y: Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension. Cancer Chemother Pharmacol 31 (Suppl 1): S60-S64, 1992
21. Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishtzaki T, Hauso K, Sugimachi K: A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma, Hepatology 10 (1): 98-102, 1989
22. Ngan H, Lai CL, Fan ST, lai ECS, Yuen WK, Tso WK: Treatment of inoperable hepatocellular carcinoma by transcatherter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Clin Radiol 47: 315-320, 1993
23. Ryder SD, Rizzi PM, Metivier E, Karani J, Williams R: Chemobebolization with lipiodol and epirubicin: applicability in British patients with hepatocellular carcinoma. Gut 38: 125-128, 1996
24. Chang J-M, Tzeng W-S, Pan H-B, Yang C-F, Lai K-H: Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. Cancer 74: 2449-2453, 1994
25. Kalayci C, Johnson PJ, Raby N, Metriver EM, Wiliams R: Intraarterial adriamicin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adraimycin. J Hepatol 11: 349-353, 1990
26. Nakamiira H, Hashimoto T, Kiromichi O, Sawada S. Transcatheter oily chemoembolisation of hepatocellular carcinoma. Radiology 170: 783-786, 1989
27. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K: The natural history of hepatocellular carcinoma: a study of 100 untreated cases. Cancer 54: 1461-1465, 1984